| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.266 | 777 | 861 | 784 | 1.146 | 767 | 1.046 | 665 | 371 | 446 |
| Total Income - EUR | 1.266 | 777 | 861 | 784 | 1.146 | 767 | 1.046 | 665 | 371 | 446 |
| Total Expenses - EUR | 1.344 | 655 | 410 | 363 | 308 | 97 | 100 | 159 | 285 | 346 |
| Gross Profit/Loss - EUR | -78 | 122 | 450 | 421 | 838 | 670 | 946 | 506 | 86 | 101 |
| Net Profit/Loss - EUR | -78 | 122 | 450 | 398 | 803 | 649 | 915 | 485 | 68 | 81 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Calinela-Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 579 | 496 | 415 | 337 | 262 | 194 | 125 | 56 |
| Current Assets | 870 | 771 | 496 | 452 | 1.084 | 1.466 | 1.833 | 1.817 | 1.943 | 2.124 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 215 | 170 | 14 | 7 | 0 | 13 | 13 | 13 | 13 | 12 |
| Cash | 655 | 601 | 482 | 444 | 1.084 | 1.453 | 1.820 | 1.804 | 1.931 | 2.112 |
| Shareholders Funds | -1.739 | -1.599 | -1.274 | -854 | -34 | 615 | 1.516 | 2.006 | 2.069 | 2.138 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.609 | 2.369 | 2.349 | 1.801 | 1.533 | 1.188 | 578 | 4 | 0 | 43 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7020 - 7020" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Calinela-Med Srl